======= HNRNPL ======= == Gene Information == * **Official Symbol**: HNRNPL * **Official Name**: heterogeneous nuclear ribonucleoprotein L * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3191|3191]] * **UniProt**: [[https://www.uniprot.org/uniprot/P14866|P14866]] * **Interactions**: [[https://thebiogrid.org/search.php?search=HNRNPL&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HNRNPL|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603083|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Splicing factor binding to exonic or intronic sites and acting as either an activator or repressor of exon inclusion. Exhibits a binding preference for CA-rich elements (PubMed:11809897, PubMed:22570490, PubMed:24164894, PubMed:25623890, PubMed:26051023). Component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes and associated with most nascent transcripts (PubMed:2687284). Associates, together with APEX1, to the negative calcium responsive element (nCaRE) B2 of the APEX2 promoter (PubMed:11809897). {ECO:0000269|PubMed:11809897, ECO:0000269|PubMed:22570490, ECO:0000269|PubMed:25623890, ECO:0000269|PubMed:26051023, ECO:0000269|PubMed:2687284}. |RRM 1| |pre-mRNA intronic binding| |ribonucleoprotein granule| |regulation of alternative mRNA splicing, via spliceosome| |regulation of mRNA splicing, via spliceosome| |regulation of RNA splicing| |regulation of mRNA processing| |ribonucleoprotein complex| |transcription regulatory region DNA binding| |mRNA splicing, via spliceosome| |RNA splicing, via transesterification reactions with bulged adenosine as nucleophile| |RNA splicing, via transesterification reactions| |regulation of mRNA metabolic process| |RNA splicing| |mRNA processing| |mRNA metabolic process| |RNA processing| |RNA binding| |RNA metabolic process| |membrane| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|-2.32| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|-1.78| |[[:results:exp504|MK2206 4μM R08 exp504]]|-1.76| |[[:results:exp421|VHL-ligand-1 20μM R07 exp421]]|1.79| |[[:results:exp349|Cytochalasin-B 5μM R07 exp349]]|1.82| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|3.73| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|5.27| ^Gene^Correlation^ |[[:human genes:c:cxorf38|CXorf38]]|0.525| |[[:human genes:f:fadd|FADD]]|0.467| |[[:human genes:e:elavl1|ELAVL1]]|0.441| |[[:human genes:c:casp8|CASP8]]|0.436| |[[:human genes:c:casp3|CASP3]]|0.435| |[[:human genes:c:ccnc|CCNC]]|0.405| Global Fraction of Cell Lines Where Essential: 177/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|3/28| |blood|9/28| |bone|7/26| |breast|6/33| |central nervous system|14/56| |cervix|0/4| |colorectal|3/17| |esophagus|5/13| |fibroblast|0/1| |gastric|4/16| |kidney|7/21| |liver|2/20| |lung|18/75| |lymphocyte|5/16| |ovary|6/26| |pancreas|5/24| |peripheral nervous system|2/16| |plasma cell|8/15| |prostate|0/1| |skin|2/24| |soft tissue|5/9| |thyroid|2/2| |upper aerodigestive|3/22| |urinary tract|6/29| |uterus|1/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1123 * **Expression level (log2 read counts)**: 9.14 {{:chemogenomics:nalm6 dist.png?nolink |}}